Archives
Cohort study: In-hospital cardiac arrest in critically ill patients with Covid-19
2 Oct, 2020 | 09:24h | UTCCommentary: Cardiac arrest, poor survival rates common in sickest patients with COVID-19 – University of Michigan
Related Study: Clinical Outcomes of In-Hospital Cardiac Arrest in COVID-19 – JAMA Internal Medicine
Commentaries on Twitter
Cardiac arrest with severe #COVID19, in-hospital:
relatively common, very poor outcome, especially w/ ⬆️age
Two series:
701 patients (14%)https://t.co/Pu0V15lemL @bmj_latest @salimhayek @umichmedicine @MHealthLab
60 patients (5%)https://t.co/Exwk68VXgg @JAMAInternalMed pic.twitter.com/9cwS0HlNxz— Eric Topol (@EricTopol) October 2, 2020
Cardiac arrest is common in critically ill patients with #COVID19 and is associated with poor survival, particularly among patients aged 80 or older, finds new research @salimhayek
https://t.co/O2Z2K3TAeT— The BMJ (@bmj_latest) October 1, 2020
Case report: Cerebrospinal fluid leak after nasal swab testing for Covid-19
2 Oct, 2020 | 09:22h | UTC
C0mmentary on Twitter
There’s been a lot of joking about getting a nasopharyngeal swab can be like a brain biopsy. Well, that actually happened https://t.co/kczvr9lIFb @JAMAOto pic.twitter.com/Lio0yV0GkS
— Eric Topol (@EricTopol) October 1, 2020
‘Provocative results’ boost hopes of antibody treatment for COVID-19
2 Oct, 2020 | 09:21h | UTC‘Provocative results’ boost hopes of antibody treatment for COVID-19 – Science
Delivering cancer care during the covid-19 pandemic: recommendations and lessons learned from ASCO global webinars
2 Oct, 2020 | 09:19h | UTC
Germans embrace fresh air to ward off coronavirus
2 Oct, 2020 | 09:18h | UTCGermans embrace fresh air to ward off coronavirus – The Guardian
Medication related hospital admissions and readmissions in older patients: an overview of literature
2 Oct, 2020 | 09:15h | UTC
India pushes bold ‘one nation, one subscription’ journal-access plan
2 Oct, 2020 | 09:10h | UTCIndia pushes bold ‘one nation, one subscription’ journal-access plan – Nature
Drug-related orthostatic hypotension: Beyond anti-hypertensive medications
2 Oct, 2020 | 09:13h | UTCDrug-Related Orthostatic Hypotension: Beyond Anti-Hypertensive Medications – Drugs & Aging
Commentary on Twitter
Drug-Related Orthostatic Hypotension: Beyond Anti-Hypertensive Medications. An open access review … https://t.co/YB0KiEiAtF pic.twitter.com/YzfsmQmtbZ
— Rohan Elliott (@elliott_rohan) September 30, 2020
Randomized trial: Hydroxychloroquine vs. placebo for pre-exposure SARS-CoV-2 prophylaxis among health care workers
1 Oct, 2020 | 09:17h | UTCCommentary: Hydroxychloroquine didn’t prevent COVID-19 among health care workers in new study – CNN
Commentary on Twitter
#Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infection, in a double-blind randomized placebo-controlled trial performed at 2 University of Pennsylvania hospitals https://t.co/7XHn6uBh4Z
— JAMA Internal Medicine (@JAMAInternalMed) September 30, 2020
HHMI, one of the largest research philanthropies, will require immediate open access to papers
2 Oct, 2020 | 09:09h | UTCRelated: UC Terminates Subscriptions with World’s Largest Scientific Publisher in Push for Open Access (several resources on the subject)
This overlooked variable is the key to the pandemic. It’s k, the dispersion factor, not R.
1 Oct, 2020 | 09:12h | UTCThis Overlooked Variable Is the Key to the Pandemic. It’s not R. – The Atlantic
Commentary on Twitter
It's k, the dispersion factor, not R. @zeynep's ★ synthesis of the opportunity to get ahead of the virus by taking advantage of the 80/20 rule for how it spreads, the avoidance of superspreading (not overlooked by me; a compelling case here)https://t.co/dZSHHdkOTA @TheAtlantic
— Eric Topol (@EricTopol) September 30, 2020
COVID has killed more than one million people. How many more will die?
1 Oct, 2020 | 09:13h | UTCCOVID has killed more than one million people. How many more will die? – Nature
Commentary on Twitter
Researchers warn that official figures underestimate the pandemic’s real death toll, which could more than triple if the virus is allowed to spread unchecked. https://t.co/H9hbI38ZEa
— nature (@Nature) September 30, 2020
Recommendations for antibacterial therapy in adults with COVID-19 – An evidence based guideline
1 Oct, 2020 | 09:15h | UTC
Commentary on Twitter
🔥Just published🔥@CMIJournal
Recommendations for antibacterial therapy in adults with COVID-19 – An evidence based guideline by the Dutch Working Party on Antibiotic Policy. #IDTwitter #COVID19 https://t.co/7cfZtS6Duv pic.twitter.com/Kz7CPMNLmh— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) September 30, 2020
The evolving picture of SARS-CoV-2 and COVID-19 in children: critical knowledge gaps
1 Oct, 2020 | 09:09h | UTC
Commentary on Twitter
The evolving picture of SARS-CoV-2 and COVID-19 in children: critical knowledge gapshttps://t.co/vPWuNytBPP pic.twitter.com/pbLY1m9ZD2
— BMJ Global Health (@GlobalHealthBMJ) September 30, 2020
Audio interview: Covid-19 testing and the individual physician
1 Oct, 2020 | 09:11h | UTCAudio Interview: Covid-19 Testing and the Individual Physician – New England Journal of Medicine
Perspective: Rethinking Covid-19 test sensitivity — a strategy for containment
1 Oct, 2020 | 09:10h | UTCRethinking Covid-19 Test Sensitivity — A Strategy for Containment – New England Journal of Medicine
Keeping best practices in critical care during COVID-19
1 Oct, 2020 | 09:08h | UTCKeeping Best Practices in Critical Care During COVID-19 – ICU Management & Practice
Commentary on Twitter
COVID-19 poses several challenges and has made it difficult to measure ICU performance.
Read the article 'Keeping Best Practices in Critical Care During COVID-19' by @f_g_zampieri 👉https://t.co/kvwlGSLBav#Covid19 #ICU #patientoutcome #FOAMcc #FOAMed pic.twitter.com/2YOhOnidxZ
— ICU Management (@ICU_Management) September 28, 2020
A systematic review and meta-analysis of published research data on COVID-19 infection-fatality rates
1 Oct, 2020 | 09:04h | UTC
Commentary on Twitter
(1/3) Excellent, rigorous review and meta-analysis of #COVID19 infection fatality ratio (IFR).
The overall IFR was 0.68% (95% CI 0.53-0.82%).
If only studies with a low risk of bias were included, the IFR rose to 0.76% (0.37-1.15%).https://t.co/F5GN0253lz https://t.co/7ucGgQ78AM pic.twitter.com/laHO3e4sl3
— Dr Zoë Hyde (@DrZoeHyde) September 30, 2020
Viewpoint: COVID-19 and heart failure with preserved ejection fraction
1 Oct, 2020 | 09:06h | UTCCOVID-19 and Heart Failure With Preserved Ejection Fraction – JAMA
New research shows older adults are still often excluded from clinical trials
1 Oct, 2020 | 09:02h | UTCNew research shows older adults are still often excluded from clinical trials – STAT
Original Study: The Exclusion of Older Persons From Vaccine and Treatment Trials for Coronavirus Disease 2019—Missing the Target – JAMA Internal Medicine
Commentary on Twitter
“It is important we have a trial population that reflects the real-world population." https://t.co/tRpo0NGL5x
— STAT (@statnews) October 1, 2020
[Abstract Only] Atezolizumab for first-line treatment of PD-L1–selected patients with non–small-cell lung cancer
1 Oct, 2020 | 08:53h | UTCCommentary: Atezolizumab Leads to Longer OS for Some Types of Advanced NSCLC, Study Says – AJMC
Invasive candidiasis in critical care: Challenges and future directions
1 Oct, 2020 | 09:00h | UTCInvasive candidiasis in critical care: challenges and future directions – Intensive Care Medicine
Commentary on Twitter
Invasive candidiasis: most common #ICU fungal infection ~40-55% mortality. Key challenges:
➡️ changing epidemiology/emergence of resistances
➡️ timely/appropriate therapy initiation/discontinuation
➡️ choosing/tailoring optimal antifungals#FOAMcc review https://t.co/tMPNcYfzwL pic.twitter.com/HvJKr0jX2o— Intensive Care Medicine (@yourICM) September 30, 2020
Systematic review: The effectiveness and cost‐effectiveness of hospital‐based specialist palliative care for adults with advanced illness and their caregivers
1 Oct, 2020 | 08:58h | UTC
Commentary on Twitter
Cochrane review on hospital-based specialist palliative care. Findings: Improved HR-QoL and patient satisfaction, reduced symptom burden and depression, and increased chances of patients dying in their preferred place. @SBajwah @cochranecollab https://t.co/wjhGp0gcbs
— Olaf Geerse (@OlafGeerse) September 30, 2020
New COVID-19 inpatient risk calculator estimates the probability of severe disease or death at hospital admission
30 Sep, 2020 | 09:51h | UTCCommentaries: COVID-19 ‘prediction model’ uses data that can help determine if patients’ conditions are likely to worsen – Johns Hopkins Medicine AND Prediction model incorporates more than 20 variables at hospital admission – Physician’s Weekly AND Patient Trajectories Among COVID-19 Hospitalized Patients – American College of Cardiology
Interactive Calculator: The COVID Inpatient Risk Calculator: CIRC
Commentary on Twitter
Lead authors Brian T. Garibaldi, MD, MEHP and Jacob Fiksel, PhD of @HopkinsMedicine developed the COVID-19 Inpatient Risk Calculator (CIRC) that uses patient data at admission to determine potential disease trajectory for #COVID19.
Link: https://t.co/i1e1ek7wO7. @Bedsidemedicine pic.twitter.com/wQLctHHYrn
— Annals of Int Med (@AnnalsofIM) September 22, 2020
[Abstract Only] Nationwide cohort study in Sweden shows HPV vaccination linked to reduced risk of invasive cervical cancer
1 Oct, 2020 | 08:56h | UTCHPV Vaccination and the Risk of Invasive Cervical Cancer – New England Journal of Medicine
News Release: HPV vaccine effective against cervical cancer – Karolinska Institutet